Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688356.SS

SELLFLAG

Jenkem Technology Co., Ltd. · Basic Materials · China · $678M · Avg Vol: $10M/d

31
StockRank
Q
70
V
20
M
32
P/E (TTM)
58.9x
ROE
5.5%
D/E
0.0x
Dividend %
0.4%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
AI CONVICTION THESIS

Jenkem is a high-quality, specialized producer of PEG derivatives critical for advanced drug delivery systems. Its high ROIC and niche moat align with the Terry Smith lens, and it stands to benefit as global biotech outsourcing shifts toward validated, high-quality chemical suppliers. However, domestic pricing pressures in China and geopolitical risks warrant a cautious stance.

COMPANY DESCRIPTION

Jenkem Technology Co., Ltd. specializes in the development and manufacture of high-purity polyethylene glycol (PEG) derivatives and linkers used in advanced drug delivery systems. The company holds a dominant global market position, serving as a critical supplier to major pharmaceutical and biotechnology firms for long-acting protein drugs and mRNA lipid nanoparticles. Its competitive moat is defined by high technical barriers in polymer synthesis and strict regulatory approvals for pharmaceutical excipients.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue60M43M34M47M-7.9%
EPS0.460.280.070.15-31.0%
Shares60M61M61M61M+0.6%
Debt685,3961M2M1M15.3%
Equity181M189M187M195M2.5%
Op CF27M18M18M12M-24.7%
Inv CF-12M-40M-6M-17M—
Fin CF-6M-6M-7M-3M—
Loading...
PRICE (1M)-26.4%
10.0011.1512.3013.4514.60May 8May 29Jun 18
SMA 50SMA 200
Close
$10.33
RSI (14)
26.5
52W High
$17.54
From 52W High
0.6%

SCORE BREAKDOWN

Quality
70
ROIC
5.2%56.3
ROE
5.5%57.3
GP/Assets
14.2%55.5
Op. Margin
33.9%89.7
FCF/Assets
-0.2%51.2
Piotroski
—81.2
Int. Cover
50.0x93.3
D/E Ratio
0.00x88.5
Current Ratio
10.41x89.0
Value
20
P/E (TTM)
58.9x18.2
EV/EBITDA
32.1x10.4
P/FCF
—N/A
P/B
3.2x31.8
P/S
12.9x12.9
Div Yield
0.4%19.8
Momentum
32
52W High %
59%26.2
RS 6M
-26%28.4
SMA 50/200
0.95x25.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
89%69.1

FUNDAMENTALS

Market Cap
$678M
P/E (Forward)
—
Gross Margin
61.3%

SECTOR PEERS

Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of 688356.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688356.SSJenkem Technology Co., Ltd.(you)$678M31SELL
003002.SZShanxi Huhua Group Co., Ltd.$656M28SELL
301190.SZJiujiang Shanshui Technology Co.,Ltd$710M28SELL
002562.SZBrother Enterprises Holding Co.,Ltd.$851M31SELL
603310.SSZhejiang Weihua New Material Co., Ltd.$822M29SELL
300537.SZJiangsu Kuangshun Photosensitivity New-Material Stock Co., Ltd.$835M32SELL
300847.SZHG Technologies Co., Ltd.$626M26SELL
300192.SZSuzhou Kingswood Education Technology Co., Ltd.$818M35SELL
301618.SZDongguan Changlian New Materials Technology Co.,Ltd.$709M22SELL
002201.SZJiangsu Jiuding New Material Co., Ltd.$1.1B31SELL

Peer medians: ROE 6.2% · P/E 33.1x · Gross margin 17.5%

Jenkem Technology Co., Ltd. (688356.SS) — Stock Score Summary

Jenkem Technology Co., Ltd. (688356.SS) has a MoatMap StockRank of 31/100 based on Quality (70/100), Value (20/100), and Momentum (32/100) factor scores. The current signal is SELL. Jenkem is a high-quality, specialized producer of PEG derivatives critical for advanced drug delivery systems. Its high ROIC and niche moat align with the Terry Smith lens, and it stands to benefit as global biotech outsourcing shifts toward validated, high-quality chemical suppliers. However, domestic pricing pressures in China and geopolitical risks warrant a cautious stance.

Jenkem Technology Co., Ltd. specializes in the development and manufacture of high-purity polyethylene glycol (PEG) derivatives and linkers used in advanced drug delivery systems. The company holds a dominant global market position, serving as a critical supplier to major pharmaceutical and biotechnology firms for long-acting protein drugs and mRNA lipid nanoparticles. Its competitive moat is defined by high technical barriers in polymer synthesis and strict regulatory approvals for pharmaceutical excipients.

Key Financial Metrics

Price$10.33
Market Cap$678M
P/E (TTM)58.86
Price/Book3.16
Return on Equity5.5%
Return on Invested Capital5.2%
Debt/Equity0.48
Gross Margin61.3%
Operating Margin33.9%
Revenue Growth14.5%
Dividend Yield0.4%
Free Cash Flow$-59K

Jenkem Technology Co., Ltd. operates in the Specialty Chemicals industry, part of the Basic Materials sector (China).

Frequently Asked Questions

What is Jenkem Technology Co., Ltd.’s (688356.SS) StockRank?
MoatMap’s StockRank for Jenkem Technology Co., Ltd. (688356.SS) is 31/100, with a Sell signal. It is a composite of Quality (70), Value (20), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Jenkem Technology Co., Ltd. have an economic moat?
Jenkem Technology Co., Ltd. (688356.SS) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jenkem Technology Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Jenkem Technology Co., Ltd. (688356.SS) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jenkem Technology Co., Ltd. in?
Jenkem Technology Co., Ltd. (688356.SS) operates in the Basic Materials sector, specifically the Specialty Chemicals industry (China).
Browse all ranked stocks688356.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock